FDA Approved: EFAVIRENZ — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Efavirenz by Aurobindo Pharma Limited, updating the product’s approval status for the treatment of HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• EFAVIRENZ (efavirenz)

Snippet

SUPPL AP for EFAVIRENZ (EFAVIRENZ)